| Keywords: |
cancer chemotherapy; cancer survival; overall survival; clinical feature; review; cancer recurrence; cancer growth; disease classification; multimodality cancer therapy; antineoplastic agents; cancer radiotherapy; combined modality therapy; cancer staging; outcome assessment; antineoplastic agent; neoplasm staging; treatment indication; progression free survival; risk factors; autologous stem cell transplantation; stem cell transplantation; pathology; algorithms; risk factor; risk assessment; survival time; patient care; feasibility study; algorithm; lymphoma, large b-cell, diffuse; transplantation, autologous; adoptive immunotherapy; immunotherapy, adoptive; neuroprotection; autotransplantation; diffuse large b cell lymphoma; cancer prognosis; epidemiological data; humans; prognosis; human; priority journal; central nervous system cancer
|
